march 19 tirzepatide US judge sides with FDA's removal of Lilly's weight loss drug from shortage list Addressing the Weight Loss Injectable
Description
Though its approval aligns with certain applications, those considering tirzepatide for weight loss should assess if Mounjaro is for weight loss or diabetes within their treatment strategy
Although these methods may offer promising results for many people, they can also present risks
2014;75:e57886
Lilly announced results from its Phase 3 TRIUMPH-4 trial of retatrutide, a first-in-class GIP, GLP-1 and glucagon triple hormone receptor agonist, on Thursday
